Trademark Overview
On Thursday, March 16, 2023, a trademark application was filed for EPISCORE with the United States Patent and Trademark Office. The USPTO has given the EPISCORE trademark a serial number of 97842069. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, August 19, 2024. This trademark is owned by Nucleix Limited. The EPISCORE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Diagnostic test kits for medical and clinical use comprised of medical diagnostic reagents for use in identifying and measuring
changes associated with cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease
and neurological disease for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic
obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; medical diagnostic assay kits comprised
of medical diagnostic reagents for use in identifying and measuring changes associated with cancer, precancerous conditions,
chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease for testing of bodily fluids for use
in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune
disease and neurological disease; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing ...
Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the
diagnosis of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease and
prognosis of expected progression of the diseases; medical testing for diagnostic or treatment purposes in the fields of the
detection and treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological
disease; providing cancer screening services; providing medical screening services for chronic obstructive pulmonary disease
(COPD) and autoimmune disease and neurological disease; providing a website featuring information in the fields of the diagnosis
and treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease
Medical apparatus for medical diagnostic testing in the fields of cancer and chronic obstructive pulmonary disease (COPD)